MedPath

Benmelstobart

Generic Name
Benmelstobart
Brand Names
安得卫

Overview

No overview information available.

Background

No background information available.

Indication

联合盐酸安罗替尼胶囊、卡铂和依托泊苷用于广泛期小细胞肺癌(ES-SCLC)的一线治疗。

Associated Conditions

No associated conditions information available.

Clinical Trials

Title
Posted
Study ID
Phase
Status
Sponsor
2025/05/28
Phase 2
Recruiting
2025/05/02
Phase 3
Not yet recruiting
The First Affiliated Hospital of Guangzhou Medical University
2025/04/17
Phase 4
Not yet recruiting
2024/12/13
Phase 2
Recruiting
Sun Yat-sen University
2024/11/21
Phase 2
Not yet recruiting
2024/09/19
Not Applicable
Not yet recruiting
Xijing Hospital
2024/07/30
Phase 2
Recruiting
Shanghai Pulmonary Hospital, Shanghai, China
2024/01/25
Phase 2
Not yet recruiting
Peking University
2023/10/31
Phase 2
Not yet recruiting
Shanghai Pulmonary Hospital, Shanghai, China
2023/02/08
Phase 3
Not yet recruiting

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
No FDA approvals found for this drug.

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Benmelstobart Injection
国药准字S20240017
生物制品
注射剂
4/30/2024

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath